Madison Dearborn Partners — Full Portfolio
6 tracked investments · listed companies and verified rows first
Option Care Health provides infusion therapy services for patients with a range of acute and chronic conditions, working with healthcare providers, health systems, hospitals, insurers, and pharmaceutical manufacturers.
Digital HealthHealthtechElmsford, US
Patricia Bogusz(Executive Officer)David Evans(Executive Officer)Kimberlee C. Seah(Executive Officer)Hai Tran(Executive Officer)Myron Z. Holubiak(Executive Officer, Director)Brian Stiver(Executive Officer)
Harmonia provides advanced technology solutions for U.S. federal government agencies, specializing in AI/ML, cybersecurity, data science, and cloud modernization using Agile and DevSecOps methodologies.
AI & Machine LearningCybersecurityEnterprise SoftwareGovTechBlacksburg, US
Pallabi Saboo(Co-founder, Strategic Advisor)Jai Saboo(Co-founder, Strategic Advisor)Marc Abrams(Co-founder, Chief Technology Officer)
Guidon Partners is a partnership of healthcare services executives that co-invests alongside private equity firms and management teams, contributing its own capital plus hands-on operating expertise.
Digital HealthHealthtechRichmond, US
Paul DiazHerb FritchNicholas J. Pace(Principal and Executive Vice President)Gregory W. Scott(Managing Director and Co-Chief Executive Officer)Kevin RuthTom Davisin
InMoment's XI Platform is a customer experience (CX) analytics and action platform that helps companies collect feedback, analyze insights, and execute improvements across customer, employee, product, and market touchpoints.
AI & Machine LearningEnterprise SoftwareMarketing TechSaaS
Co-investorsJMI EquityPeterson Venture Partners
Zilliant provides an AI-driven pricing platform that automates and optimizes pricing operations for B2B companies using real-time data intelligence.
AI & Machine LearningEnterprise SoftwareSaaSSales Tech
Co-investorsEscalate Capital PartnersHouston VenturesGoldman Sachs
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.









